Tolmar Executive and Leadership Team

Jeff Lederman, the Chief Financial Officer at Tolmar, directs all fiscal planning and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures robust investment in product development and manufacturing infrastructure. This leadership role involves managing complex budgetary requirements across the Northern Colorado headquarters and the Illinois commercial hub. By optimizing capital structures, Jeff Lederman directly impacts the long-term sustainability of the pharmaceutical pipeline. Lederman maintains rigorous oversight of financial reporting and risk management protocols to support the broader corporate mission. Through precise fiscal governance, the Chief Financial Officer enables the company to scale operations effectively while maintaining a competitive edge in the specialty pharmaceutical market. Lederman secures the necessary resources to drive innovation in urology, ensuring that financial performance aligns with the strategic goals of the entire enterprise.

Shawn Silvestri, the President & Chief Operating Officer at Tolmar, manages the end-to-end execution of manufacturing and product development initiatives. Overseeing the operational efficiency of facilities in Northern Colorado, the President & Chief Operating Officer ensures seamless integration between research and commercialization. This leadership role involves coordinating cross-functional teams to maintain high standards in pharmaceutical production. By streamlining supply chain logistics and manufacturing workflows, Shawn Silvestri directly impacts the availability of specialty treatments for patients. Silvestri drives continuous improvement programs to enhance operational agility across the entire organization. Through strategic oversight of daily business activities, the President & Chief Operating Officer maintains alignment with the company's commitment to urological excellence. Silvestri fosters a culture of precision and quality, ensuring that every stage of the product lifecycle meets rigorous regulatory and performance benchmarks.

Steve Griffin, the President (North America) at Tolmar, executes the commercial strategy and market expansion efforts across the region. Overseeing the commercial headquarters in Illinois, the President (North America) ensures that specialty pharmaceutical products reach target patient populations effectively. This leadership role involves managing sales force performance and regional market penetration. By driving North American initiatives, Steve Griffin directly impacts the company's revenue growth and market share in the urology space. Griffin coordinates with other C-suite leaders to align commercial activities with manufacturing capabilities. Through the development of regional partnerships and customer engagement strategies, the President (North America) strengthens the company's competitive position. Griffin fosters a high-performance culture within the commercial teams, ensuring that the organization meets its strategic objectives while delivering essential therapeutic solutions to the healthcare community.

Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, architects the clinical strategy and commercial positioning for the company's specialty pharmaceutical portfolio. Overseeing medical affairs and market access, the Chief Medical Officer & Chief Marketing Officer ensures that clinical data effectively informs commercial outreach. This leadership role involves bridging the gap between scientific innovation and patient needs within the urology sector. By aligning medical evidence with marketing campaigns, Anjan Chatterjee directly impacts the adoption of therapeutic solutions across North America. Chatterjee manages the communication of clinical value to healthcare providers and stakeholders. Through the integration of medical expertise and market intelligence, the Chief Medical Officer & Chief Marketing Officer drives the successful launch and growth of key products. Chatterjee ensures that the company's market presence remains grounded in scientific integrity and patient-centric care.

Michael Elm, the Chief Legal Officer at Tolmar, directs all legal affairs, regulatory compliance, and intellectual property protection. Overseeing the legal framework for the company's manufacturing and commercial operations, the Chief Legal Officer ensures adherence to complex pharmaceutical regulations. This leadership role involves mitigating corporate risk while supporting the development of innovative urology products. By providing strategic counsel to the executive team, Michael Elm directly impacts the company's ability to navigate the evolving regulatory landscape. Elm manages contractual obligations and legal disputes to protect the organization's interests. Through proactive legal planning, the Chief Legal Officer enables the business to pursue growth opportunities with confidence. Elm maintains a focus on ethical standards and compliance, ensuring that all corporate activities align with legal requirements and industry best practices across the entire North American market.